SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported first-quarter earnings of $3.6 million.
On a per-share basis, the San Diego-based company said it had profit of 2 cents.
The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.
The drugmaker posted revenue of $268.1 million in the period, which also fell short of Street forecasts. Six analysts surveyed by Zacks expected $282.2 million.
Acadia expects full-year revenue in the range of $1.22 billion to $1.28 billion.
Acadia shares have decreased 19% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.70, a rise of 49% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
/Palantir%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock.jpg)
/Robinhood%20app%20on%20phone%20by%20Andrew%20Neel%20via%20Unsplash.jpg)